FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
216203NDALEXICON PHARMS INC001INPEFATABLET;ORAL200MGSOTAGLIFLOZIN2023-05-26PrescriptionNo
002INPEFATABLET;ORAL400MGSOTAGLIFLOZIN2023-05-26PrescriptionYes